PROCESS FOR CHROMATOGRAPHIC SEPARATION OF PEPTIDES AND NUCLEIC ACID, AND NEW HIGH AFFINITY ION EXCHANGE MATRIX

Abstract: Process for separating off a peptide or a nucleic acid by an anion exchanger (I) characterized in that a) the anion exchanger (I) exhibits ligands, which (i) contain a primary, secondary or tertiary amino group and (ii) are covalently bound to an organic polymer (matrix), b) there on a carbon atom at a distance of 2 or 3 atoms away from an amino nitrogen in the ligands is a hydroxyl group or a primary, secondary or tertiary amino group, and c) the maximum elution ionic strength in the pH range 2-14 for at least one of the proteins transferrin, ovalbumin 1, ovalbumin 2, beta -lactoglobulin 1 and beta -lactoglobulin 2 on the anion exchanger (I) is higher than the elution ionic strength required for a quaternary comparative ion exchanger. Chromatofocusing and separation on ECTEOLA-cellulose is not included. New anion exchangers which are according to structure (I) wherein R1-6 are hydrocarbon groups which can contain ether oxygen atoms, hydroxyl groups, and different types of amino groups. X is OH or alkoxy or amino. B is a ligand arm replacing a group R1-6 or a hydrogen in any of R1-6. If one of the groups R5 and R6 contains a nitrogen atom then one of the groups also contains a hydroxy or alkoxy group. ECTEOLA-cellulose and variants where both R5 and R6 are selected among methyl and ethyl are not included.

Description: Process forchromatographic separation ofpeptidesand nucleic acid,and new high affinityion exchange matrix Field of the invention and definitions The present invention relates to weak anion exchangers, i.e. ion exchangers exhibiting protonated forms of primary, secon¬ dary or tertiary amino as anion exchanging ligand. The inven¬ tion is based on our discovery that this type of anion exchang¬ ers, when having certain hydrogen binding atoms at a distance of 2 or 3 atoms away from the nitrogen in the weak anion ex¬ changing group of the ligand, can exhibit enhanced binding properties to peptides or nucleic acids. Because the binding is broken by guanidine or urea, this has been construed as a pres¬ ence of hydrogen bonds between peptide/nucleic acid and anion exchanging ligand. Our discovery has led to both a new process for separating nucleic acid or peptide, and new ion exchange adsorbents (ion exchanging matrices) which can be used in the method. By amino group (structures and expression) is meant, if not otherwise stated, a protonated and non-protonated primary, sec¬ ondary, tertiary amino group as well as a quaternary ammonium group. By the expression "to separate" is meant removing or separat¬ ing off one or more nucleic acids/peptides from a more or less complex mixture of substances. Separation can be used in con¬ nection with isolation, purification, and analysis of nucleic acid/peptide. Separation is effected by way of substances in¬ teracting with the ligands of the anion exchanger. The interac¬ tion is different for different substances which leads to sepa- ration. By nucleic acid is meant both RNA and DNA, including single and double stranded or modified forms of these, such as phos- phothionate forms which exhibit protecting groups and markers (isotope, biotin, hapten etc.) . Nucleic acid can be an oligo- or poly-nucleotide. The number of bases and basepairs, respec¬ tively in oligonucleotides is typically ≤ 200. The invention is preferably applied to isolation and purification of syntheti- cally produced oligonucleotides. By peptide is meant compounds exhibiting polypeptide struc¬ ture, i.e. proteins, such as lipoproteins, glycoproteins, pro- teoglycans etc., and oligopeptides (i.e. peptides having 2-10 amino acids) . Prior Art EP 276,138 and DE 3,935,098 describe anion exchangers exhib¬ iting weak anion exchanging groups having a hydroxyl group at a distance of two carbon atoms away from a nitrogen in the ion exchanging group. The ion exchanging group has been introduced using a bifunctional reagent which, through a silane group cou¬ ples to a glass matrix and through an epoxide to a primary or secondary amino glass-O-Si- (CH 2 ) 3 -0-CH 2 CHOHCH 2 -NH- (CH 2 ) 2 -OH Silane structures are relatively unstable and restrict the range of available pH values. EP 276,138 suggests that the ma¬ trix also can be an organic polymer. However, concerning or¬ ganic matrices, it is uncertain if enough stable products can be obtained in the suggested way. Both publications are related to separation of polynucleotides. DE 3,935,098 does also use an eluent which contains the denaturating agent urea. A more de¬ tailed explanation is not given. EP 167,488 also describes ion exchangers exhibiting weak ion exchanging groups having a hydroxyl group at a distance of two carbon atoms away from a nitrogen atom. The ion exchanging group binds through an amide to the matrix. Nothing is men¬ tioned regarding separation of peptides or nucleic acid. The inventors of EP 276., 138 turn down our types of ligands since they find their binding ability too strong. The explana ¬ tion is wrong which probably also is the reason for them not to understand to utilize the general feature on which the strong binding ability of our novel ligands is based (hydrogen- bonding) . Probably, they have not even realized the need for binding at high ionic strength. There is also a relatively wide range of literature regarding ECTEOLA cellulose for purification of nucleic acid. ECTEOLA cellulose has been produced by coupling triethanolamine, N(CH 2 CH 2 OH) 3 to cellulose using epoxide. It has been considered that the resulting groups are -CH 2 CHOHCH 2 -N + (CH 2 CH 2 OH) 3 , i.e. ECTEOLA cellulose is a strong ion exchanger. However, it has been shown that commercial variants of ECTEOLA cellulose have relatively high buffer capacity at pH 7-10, which indicates presence of weak ion exchanging groups, which in turn means that hydroxyl groups in triethanol amine has been used for binding to cellulose. Ion exchangers based on triethanol amine, which through reaction with epoxide, have been coupled to cel- lulose are not comprised within the scope of the new matrices of the invention. Weak ion exchangers with ligands which are polyvalent in re¬ lation to an amino group have previously been used for chroma¬ tofocusing. By this type of chromatography an internal pH gra- dient is generated on the column. Adsorption and elution is performed with low ionic strengths, to avoid bound substances to be displaced by salts in the buffer. Presently used ionic strengths for adsorption are < 50 mM NaCl, typically < 30 mM. For elution the ionic strengths are even lower (5 fold lower) . See Sluyterman et al., "Ten years of chromatofocusing: a dis¬ cussion" (J, . Chromatog. 470(2) (1989) 417-426). According to this definition chromatofocusing is not within the scope of the process of the invention. Summary of invention In chromatography there is a general need for obtaining im¬ proved methods for separation of peptides and nucleic acid. Es¬ pecially can be mentioned purification of proteins from super¬ natants derived from fermentation and other cell culture plants. These media often contain high levels of salt (conductivity ≥ 15-20 mS/cm) making them difficult to apply di¬ rectly on conventional ion exchangers. Pretreatment must be done, for example by desalting or dilution, which in turn leads to more expensive process costs. There is also a need for ion exchange adsorbents giving adsorption at high ionic strength, preferably at ionic strengths which correspond to conductivi¬ ties of ≥ 15-20 mS/cm, and which can be desorbed at low ionic strengths, for example by a simple adjustment of pH. Synthetically produced oligonucleotides are often purified on ion exchangers. In addition to the oligonucleotide which is in- tended to be produced, the synthesis usually also gives shorter variants. Obtained oligonucleotides usually have the terminal protecting group left. This leads to difficulties in purifica¬ tion and processing. It is often desirable to be able to per¬ form chromatography and deprotection in one step. There is also a desire for improved ion exchange methods, which give improved dynamics, improved capacity and a reduced number of steps for purification and isolation of peptides and nucleic acid. The invention The discovery of the initially mentioned enhanced binding properties has enabled us to provide anion exchangers (I) show- ing greater dynamics in the separation of proteins and nucleic acid. This can be expressed in such a way that the maximum elu¬ tion ionic strength in the pH range 2-14 for the anion ex¬ changer (I) is higher than, in preferred cases ≥ 125%, in many cases ≥ 140%, such as ≥ 200% of the required elution ionic strength for a quaternary anion exchanger (II) with ion ex¬ changing group (CH 3 ) 3 N + - (=Q-group; the same matrix, same cou¬ pling group from the quaternary nitrogen and in towards the ma¬ trix, the same level of ligand as for the anion exchanger (I) and measured at the same pH) for desorption of at least one of the proteins given in the experimental part (see figure 3), transferrin, ovalbumin 1, ovalbumin 2, β-lactoglobulin 1 and β- lactoglobulin 2) . The variation of the elution ionic strength with pH of the anion exchanger that was used according to the invention for certain proteins is illustrated in figure 2A. In the method according to the invention a solution contain¬ ing the nucleic acid and/or peptide, which is to be separated off, is contacted with an anion exchanger, exhibiting ligands with positively charged amino groups, covalently coupled to a polymer matrix, under such conditions that a desired peptide and/or nucleic acid in the sample separates from at least one further substance in the solution (adsorption step) . In case separated peptide/nucleic acid has become adsorbed to the anion exchanger it can, if desired, be desorbed by an eluent. The method is characterized in that the used anion exchanger has amino groups, which are primary, secondary or tertiary, and that on at least one carbon atom, being at a distance of 2 or 3 atoms away from the amino nitrogen in the anion exchanging group, there is a hydroxyl group or a primary, secondary or tertiary amino nitrogen. In the characterized portion of the method is also included that the anion exchanger (I) is se¬ lected so that at least one of the proteins given in the ex- perimental part (figure 3; transferrin, ovalbumin 1, ovalbumin 2, β-lactoglobulin 1 and β-lactoglobulin 2) requires elution ionic strengths as above. The solution (including the eluent) applied on the anion ex- changer is typically aqueous consisting of water, possibly com¬ prising a liquid miscible with water, for example ethanol, methanol, acetonitrile, mixtures miscible with water etc. The solution may also be any of the above mentioned organic sol¬ vents. The solutions, especially eluents, often contain salts, buffer substances, substances which break hydrogen bonds etc. The solution containing nucleic acid/peptide, can be a super¬ natant of a cell culture, but can also be a synthesis mixture, possibly partially processed, or an extract. The ionic strength in the solution should be such that it enables the desired binding/adsorption to the ion exchanger. Depending on ion ex¬ changing groups and protein or oligo-/poly-nucleotide, which is to be adsorbed, the ionic strength/conductivity can be higher or lower than 15-20 mS/cm. ANION EXCHANGERS TO BE USED ACCORDING TO THE PROCESS OF THE INVENTION Preferred anion exchangers are represented by formula I. Sev¬ eral of them are new. The man skilled in the art can by simple experiments in ways that are shown in the experimental part (Experiment 2C) decide whether an ion exchanger meets the above mentioned criteria for elution ionic strength. ligand ligand arm (B) plus matrix (M) FORMULA 1 means that the ligand arm replaces a group R 1 . 6 or a hy¬ drogen in any of the groups R x _ 6 in the ligand. Preferably the ligand arm is replacing R λ or R 5 or R 6 . The ligand often has a molecular weight of ≤ 1000. M is a matrix and contains additional ion exchanging ligands, typically according to formula I. n is an integer of 1 or 2, typically 1. R ±.6 is selected among hydrogen and linear, branched or cyclic saturated or unsaturated hydrocarbon group, which can be raono- valent or divalent. Divalent groups consist of two connected groups Rι_ 6/ so that a 5 or 6 membered ring is formed together with any of the atoms in formula I marked with bold letters. Typical examples of pairs of R x . 6 , forming divalent groups, are R 5 and R 6 , Rx and R 5 or R : and R 6 . In contemplated hydrocarbon groups the carbon chain can be disrupted by one or more amino nitrogen or ether oxygen atoms (-NR 7 - and -0- respectively) and/or one or more hydrogens can be substituted by an amino group (-N + R 8 R 9 Rιo) or by a group -OR . One and the same carbon atom binds, apart from to carbon and hydrogen, typically to maximum one oxygen or nitrogen atom. Contemplated carbon chains, including possible disruptions of oxygen or nitrogen atoms, are generally ≤ 10 atoms in length, preferably 6 or fewer atoms. R^g can exhibit one or more ether oxygen atoms, hydroxyl groups or amino nitrogen atoms at a distance of 2 or 3 atoms away from the nitrogen atom, to which R 5 and R 6 bind (above all in R 5 and R 6 ) . R lf R 3 and R 4 are preferably hydrogen. In the case where n = 2, R 3 and R 4 on one of the carbon atoms can be different from those on the other carbon atom. Either or both of R 5 and R 6 can be hydrogen. If either of R 5 and R 6 is hydrogen it is preferable if the other is unsuosti- tuted alkyl (C n H 2n+1 - or corresponding cyclic forms C n H 2n -; n is an integer, generally 1-10) . R 5 and R 6 can not simultaneously be selected among methyl and ethyl. Examples of R^g are lower alkyl (having 1-6 carbon atoms) , such as methyl, ethyl, n-propyl, isopropyl-, n-butyl-, sec- butyl, t-butyl and isobutyl, including corresponding forms sub¬ stituted by a group -N + R 8 R 9 R 10 or -OR . Exemplary substituted forms are hydroxymethyl; -hydroxyethyl; 2-hydroxypropyl; 2- hydroxy-1-methylethyl; l-hydroxymethyl-2-hydroxyethyl; 2- hydroxybutyl; 1- (hydroxymethyl)propyl; l-methyl-2- hydroxypropyl; 2-hydroxy-l, 1, -di (hydroxymethyl) ethyl; 1,1- di (hydroxymethyl) ethyl; 1-hydroxymethyl-l-methylethyl; 1,1- di (hydroxymethyl)propyl-; 2, 3-dihydroxypropyl; 2,3,4- trihydroxybutyl-; 2, 3, 4, 5-tetrahydroxypentyl and 2,3,4,5,6- pentahydroxyhexyl- and corresponding amino groups where for ex¬ ample -NH 2 substitutes one or more -OH. R 7 . 12 are selected among the same groups as R^g, preferably one, two, three or four of R 7 _n are hydrogen or lower alkyl C 2 _ 6 . In the case where all R 8 _ 10 are alkyl groups -N + R 8 R 9 R 10 is a quaternary ammonium group. Divalent hydrocarbon groups which can be formed by pairs of groups R^ are for example -CH 2 CH 2 - and -CH 2 CH 2 CH 2 -; -CH 2 CH 2 CH 2 CH 2 -; -CH 2 CH 2 CH 2 CH 2 CH 2 -; -CH 2 CH 2 OCH 2 CH 2 -; -CH 2 CH 2 NHCH 2 CH 2 -; -CH 2 NHCH 2 CH 2 -; -CH 2 OCH 2 CH 2 -; -CH 2 CH 2 CHOHCH 2 CH 2 - and -CH 2 CH 2 CH[N + (CH 3 ) 3 ]CH 2 CH 2 -. X is -OH or -NR 12 R 13 , where R 1 -ι 3 are selected among the same groups as R l f R 3 , R 5 , and R 6 . In the most common case at least one of R i2 _ι 3 is hydrogen, i.e. -NHR 12 or -NHR 13 . The ligand arm is an organic structure which is hydrolyti- cally stable under pH conditions normally utilized for anion exchange chromatography, i.e. pH 2-14. The ligand arm lacks typically hydrolytically unstable structures, such as silane, carboxylic acid ester (-C00-) or carboxylic acid amide (-CONH-) . The ligand arm is preferably a linear, branched or cyclic saturated or unsaturated hydrocarbon chain, which op¬ tionally is broken by one or more ether oxygen- and/or amino nitrogen atoms (-NR' 7 -) or substituted by one or more groups -N + R' 8 R' 9 R' ιo or -OR'n- R' -ιι are selected according to the same rules as for R 7 _ u . In the most common case R' 7 , R' n and at least one of R' 8 _ 10 are hydrogen, preferably two or three. The R' 7 _ 11 , that are not hydrogen, are typically lower alkyl (having 1-6 carbon atoms) . One and the same carbon atom in the ligand arm binds, apart from carbon and hydrogen, typically to at the most one oxygen or nitrogen atom. Preferred ligand arms B often have a length of 0-20 atoms. The ligand arm B often derives from couplings involved in a re¬ actions between epoxide or -CH 2 X' (where X'=halogen, which can be replaced by another functionally equivalent group, such as tosylate) and ammonia, primary, secondary amino (NHR 5 R 6 , where R 5 and R 6 are according to above) or alcoholic hydroxyl. The group -CH 2 X' can be included in halohydrin, alkyl halide, vici¬ nal dihalide etc. Preferred couplings is effected via epoxide, halohydrin and vicinal dihalide, as they per se lead to a hy¬ droxyl group that is β (at a distance of 2 carbon atoms away) to an amino group. Coupling via epoxide, halohydrin and vicinal dihalide means that in formula I n =1, X = OH and R 3 . 4 = H, i.e. the structure nearest to NR 5 R 6 becomes -CH 2 CHOHCH 2 - . Example of preferred structures -B-CHXCR 3 R 4 - which can be formed as a re¬ sult of this type of couplings are -CH 2 CHOHCH 2 -0-CH 2 CHOHCH 2 -; -CH 2 CHOHCH 2 -0- (CH 2 ) 4 -0-CH 2 CHOHCH : -; -CH 2 CHOHCH 2 - etc., i.e. B is -CH 2 CHOHCH 2 -0-CH 2 -; -CH 2 CHOHCH 2 -0- (CH 2 ) 4 -0-CH 2 -; -CH 2 -. Epoxide-/vicinal dihalide-/halohydrin groups can be introduced in a known way by allylation of a polymer containing hydroxyl group (s), for example by reaction with allylglycidyl ether, and subsequent halogenation. See e.g. Nochumsson S (EP 87995) and Lindgren G (WO 9404192) . The ligand arm B binds typically to the matrix M through an ether structure where the ether oxygen derives from a hydroxyl in the matrix. Thioether (-S-) and sulphonamide (-S0 2 NH-) have comparable hydrolytic stability with ether and can thus equivalently re- place ether in the ligand arm or in the groups R ! _ 13 or R' 7 -n- Preferred ligands are formed if the following compounds are re¬ acted with matrix bound epoxide/halohalide/vic al dihalide: Compound Ligand (nonprotonated form) Ammonia -CHOHCH 2 NH 2 propylamine -CHOHCH 2 NHCH 2 CH 2 CH 3 triethylenetetraamine -CHOHCH 2 NHCH 2 CH 2 NHCH 2 CH 2 NHCH 2 CH,NH 2 bisaminopropylamine -CHOHCH 2 NH(CH 2 ) 3 NH(CH 2 ) 3 NH 2 or -CHOHCH 2 N [ (CH 2 ) 3 NH 2 ] 2 t-butylamine -CHOHCH 2 NH[C(CH 3 ) 3 ] ethanolamine -CHOHCH 2 NHCH 2 CH 2 OH diethanolamine -CHOHCH 2 N (CH 2 CH 2 OH) 2 tris (hydroxymethyl) - -CHOHCH 2 NHC (CH 2 OH) 3 methylamine 2-amino-l, 3-propane- -CHOHCH 2 NHCH (CH 2 OH) 2 diol 3-amino-l, 2-propane- -CHOHCH 2 NHCH 2 CHOHCH 2 OH diol 2-amino-2-methyl- -CHOHCH 2 NHC(CH 3 ) (CH 2 OH) 2 1, 3-propanediol 1-amino-deoxysorbitol -CHOHCH 2 NHCH 2 (CHOH) 4 CH 2 OH 2-glucoseamine bis- (tris (hydroxy- -CHOHCH 2 N [C (CH 2 OH) 3 ] (CH 2 ) 3 NHC (CH 2 OH) methy l ethy 1 ) amino ) propane The shown ligands have been formed as a result of coupling through the amino nitrogen. Alternatively coupling can be ef¬ fected at a hydroxyl group, giving other ligands according to formula I . This means that one and the same anion exchanger ac¬ cording to the invention often exhibits one or more ligands ac- cording to formula I. The coupling reaction can be directed so that it occurs more or less selective at either the amino ni¬ trogen or the hydroxyl oxygen. It appears that the ligand can contain atoms both from the compound which is coupled to the matrix and from the reactive group utilized for coupling. At the date of priority, the most preferred ligands for sepa¬ ration of nucleic acid were those which are formed if matrix bound vicinal dihalide, halohydrin or epoxide is reacted with t-butylamine, 2-amino-l, 3-dihydroxypropane, tris (hydroxymethyl)methylamine, ethanolamine or n-propylamine. The preferred anion exchangers for peptide separation require elution ionic strengths of more than, typically ≥125%, in many cases ≥140%, such as ≥200%, of the elution ionic strength which, according to above, is required for a quaternary ion ex¬ changer with Q-groups for desorption of at least one of the proteins given in the experimental part (figure 3) . The matrix M in the invention is generally a hydrophilic polymer insoluble in water, which also includes hydrophobic polymers which have been derivatized so as to be hydrophilic. Examples are polyhydroxy polymers based on polysaccharides, such as agarose, dextran, cellulose, starch, pullulane etc., and purely synthetic polymers, such as polyacrylamide, poly- methacrylamide, poly (hydroxyalkyl vinyl ethers), poly (hydroxyalkyl acrylate) and corresponding polymethacrylate, polyvinyl alcohol, and polymers based on styrene and div yl- benzene (DVB), and copolymers where corresponding monomers are included. Polymers soluble in water, can be derivatized to in- solubility, e.g. by cross-linking or by attachment via adsorp¬ tion or covalent binding to an insoluble body. Hydrophilic groups can be introduced on hydrophobic polymers (e.g. styrene- DVB-copolymers) by effecting polymerisation together with mono¬ mer, having groups which can be transformed to OH, or by hydro- philization of the final polymer, e.g. by adsorption of suit¬ able compounds, such as hydrophilic polymers. The matrix is of¬ ten porous to increase the surface, which is contacted with surrounding liquid. Polymer arms (tentacles) can also be in¬ cluded in the matrix, each arm exhibiting one or more ligands bound via the ligand arm B according to formula I. Preferred matrices lack hydrolytically unstable groups such as silane, ester and amide groups. The level of ligand according to formula I in the ion ex¬ changers of the invention and in the ion exchangers which can be used in the method of the invention is generally in the range of 0.001-4 mmole, preferably 0.01-1 mmole, per ml matrix saturated with water. Possible and preferred ranges are deter¬ mined by the structure of the matrix. The level of ligand is thus for agarose-based matrices generally in the range of 0.1- 0.3 mmole per ml swelled matrix (gel) . For dextran-based matri¬ ces the range can be expanded up to 0.5-0.6 mmole per ml swelled matrix (gel) . Contemplated levels of ligand are deter¬ mined in a way that is shown in the experimental part. THE NEW ANION EXCHANGERS OF THE INVENTION These are according to formula I with the additional condi- tions that if one or two of the groups R 5 and R 6 contains one or more nitrogen atoms then at least one of the groups also contains one or more oxygen atoms (-OR llf where R u is according to above) . Both R 5 and R 6 and cannot at the same time be se¬ lected among methyl and ethyl. Preferred forms of the ion ex- changers of the invention exhibit elution ionic strengths ac¬ cording to above. Anion exchangers produced by coupling of triethanolamine via a reaction with epoxide are not a part of this aspect of the invention. The meaning of , n, B, M, X, Rχ- 4 , 7 _ιι and R' 7 _ u is the same as for formula I. STEPS OF THE METHOD The adsorption in the process of the invention is performed in a way which has been stated above. By, after the adsorption step, possibly after intermediate washing, raising the ionic strength in an aqueous eluent and/or adding a denaturating agent and/or by varying pH, it is possi¬ ble in a known way to selectively desorb substances, which have been adsorbed, for example peptides and nucleic acid, and col¬ lect the desired substance in a purified form in the eluate. Changes of ionic strength, presence of denaturating agents and pH can be performed gradually (one or more steps) or in form of a continuous gradient. Desorption, especially for peptides, can be performed at higher ionic strength than what is required on desorption of the same substance from a quaternary ion exchanger with Q-group according to above. Typical agents which break hydrogen bonds (denaturating agents) are guanidine and urea. Information regarding agents which break hydrogen bonds see Levine et al., Biochemistry 2 (1963) 168-175. Depending on how tightly the substance to be desorbed binds to the ligand and the choice of agents which break hydrogen bonds , the concentration of agents which break hydrogen bonds may vary from 0 M up to the solubility for re¬ spective agent. Typical levels of agents which break hydrogen bonds are in the range of 0.1 M up to 5 M. As an agent which breaks hydrogen bonds on desorption, the ligand of the ion ex¬ changing matrix can also potentially be used in free form or a homologous compound according to the formula FORMULA II where R x - g , n and X have the same meaning as in formula I. Change of pH can per se lead to breaking of hydrogen bonds . Use of denaturating/hydrogenbond-breaking agents is above all applicable for separation of nucleic acid and can easily be combined with a salt gradient (=conductivity gradient) or changes of pH. Generally speaking, if the adsorption involves a significant portion of hydrogen bonds , desorption can be performed at relatively low ionic strengths if agents which break hydrogen bonds (e.g. free ligand) are included in the desorption solu¬ tion or by raising pH so that the ligand is unloaded and the hydrogen bonds are impaired. Salt desorption (possibly in form of gradient) can be used for both peptides and nucleic acids and means that the concen- tration of salt (ionic strength) is increased. The increase may vary from 0 M up to the solubility for respective salt. The in¬ crease is often in the range of 0.01-4 M. pH for the initially applied aqueous solution and the eluent may vary. For peptides, which principally are bound to the ad- sorbent through ionic interaction, the greatest differences in elution ionic strengths for different proteins are obtained at a pH where the weak anion exchanging groups are positively charged and the peptide which is to be separated is negatively charged. This means generally that too high pH values (> 10) and too low pH values are to be avoided. The interaction of hy¬ drogen binding character means that the present type of anion exchanger also can bind weakly positively charged proteins (see figure 2A) . The pH of the eluent used for desorbing adsorbed nucleic acid/peptide is preferably adjusted so that buffering compo¬ nents not can bind to the ligand of the anion exchanger, i.e. they are positively charged. Suitable buffer components are cationic bases and acids, such as amines, and zwitterions. Buffering components in utilized eluents are typically within the concentration range of 10-50 mM. The process of the invention according to the above can be seen as using anion exchangers for separation according to the above with the condition that chromatofocusing according to the above and separation on ECTEOLA-cellulose are not included. The invention can be used for conventional chromatography on a packed and fluidized bed in column, batchwise adsorption pro- cedures etc. The matrices can be in form of particles (beads) , monolitic or in form of surfaces (e.g. in sensors) . FIGURES I. Results from chromatography of proteins Figure 1: Chromatography for comparison of agarose gel with tris-ligand described above (ligand according to for¬ mula I = (HOCH 2 ) 3 CH 2 NCH 2 CHOH-, ligand arm -CH 2 OCH 2 CHOHCH 2 -) and with Q-ligand (ligand = (CH 3 ) 3 N + CH 2 CHOH-, ligand arm -CH 2 OCH 2 CHOHCH 2 -) . Broken line chromatogram refers to Q-ligand (Q-Sepharose(E> HP, Pharmacia Biotech AB, Uppsala, Sweden) . Solid line chromatogram refers to tris-ligand. Figures 2A and 2B: pH dependence of the elution ionic strength for proteins on above-described agarose gels with tris-ligand (2A) and Q-ligand (2B) , respectively. Figure 3: Elution ionic strengths - comparison between differ¬ ent anion exchange ligands: A-C. Q-ligand 0.03, 0.11, 0.17 mmol/ml, respectively D. ammonia 0.10 mmole/g; E. bisaminopropylamine 0.31 mmole/g; F. propylamine 0.13 mmole/g; G. t-butylamine 0.15 mmole/g; H. ethanolamine 0.14 mmole/g; I. diethanolamine 0.15 mmole/g; J. triethanolamine 0.06 mmole/g; K. 2-amino-l, 3-propanediol 0.14 mmole/g; L. 3-amino-l, 2-propanediol 0.14 mmole/g; M. 2-amino-2-methyl-l, 3-propanediol 0.15 mmole/g; N. tris (hydroxymethyl) aminomethane 0.12 mmol/g O. bistrispropane 0.11 mmole/g) ; P. aminosorbitol 0.11 mmole/g; Q. methylmorpholine 0.12 mmole/g; R. morpholine 0.28 mmole/g II . Results from chromatography of nucleic acid Figure 4: Experiment 1. Elution at pH 7 with salt followed by urea . Figure 5: Experiment 2. Elution at pH 7 with urea followed by salt . Figure 6: Experiment 3. Elution at pH 7 with salt gradient Figure 7: Experiment 4. Elution at pH 9 with salt. pH for loaded sample 8.2. Figure 8A: Experiment 5. pH for loaded sample 6.8. Elution with salt followed by salt plus urea. Figure 8B: Experiment 6. pH for loaded sample 9.0. Elution with salt. EXPERIMENTAL PART 1. SYNTHESIS OF ION EXCHANGER. A. Standard method (ion exchanger of the invention) . Cross-linked agarose (30 μ particles) prepared by reaction between epichlorohydrin and agarose in the presence of NaOH ac¬ cording to Porath et al (J. Chromatog. 60 (1971) 167-77 and U.S. 3,959,251) was reacted with allylglycidyl ether with NaOH as a base to a allyl level (CH 2 =CHCH 2 OCH 2 CHOHCH 2 -) of 0.18-0.22 mmole/ml) . 40 g of the cross-linked allylated agarose washed with water was added together with 160 ml distilled water and 9.2 g sodium sulphate in a 400 ml beaker equipped with a sus¬ pended magnetic stirrer, after which bromine water was added to remaining yellow dyeing. Reduction of excess of bromine was ef¬ fected with sodium formiate, after which the gel was washed with distilled water (> 5 bed volumes) , dry suctioned for 15-30 seconds. Subsequently the brominated gel was added together with 60 ml distilled water and 60 g tris (hydroxymethyl) amino- methane (= tris, gives the ligand (HOCH 2 ) 3 CH 2 NCH 2 CHOH- (according to formula I, herein below this ligand is called tris-ligand and the ion exchanger is called tris-ion exchanger) in a 3-necked 100 ml Bellco-flask with suspended magnetic bar. Initially the pH was 10.9. The reaction was continued over night (23 hours) at 40°C. pH after completion of reaction time was 10.0. Subsequently, the gel was washed thoroughly with dis¬ tilled water (> 10 bed volumes) and possible storage was con- ducted in distilled water containing 23 % (w/w) ethanol. Inflection point titration directly on the substituted matrix with NaOH-solution gave a level of ligand of 0.13 mmole/g dry suctioned gel. Starting from cross-linked allylhydroxypropyl agarose, ac- cording to above, ammonia (0.10 mmole/ml), bisaminopropylamme (0.31 mmole/ml), propylamine (0.13 mmole/ml), t-butylamine (0.15 mmole/ml), ethanolamine (0.14 mmole/ml), diethanolamine (0.15 mmole/ml), triethanolamine (0.06 mmole/ml), 2-am o-l,3- propanediol (0.14 mmole/ml), 3-amino-l, 2-propanediol (0.14 mmole/ml) , 2-amino-2-methyl-l, 3-propanediol (0.15 mmole/ml), bistrispropane (0.11 mmole/ml), aminosorbitol (0.11 mmole/ml) and methylmorpholine (0.12 mmole/ml) were coupled in an analo- gous way. The ion exchange capacity is put within brackets for each complete ion exchanger. B. Quaternary ion exchanger (Q-ion exchanger; comparative ion exchanger) . These were prepared from cross-linked agarose produced ac¬ cording to the above, substituted with allyl-groups in an amount that matched predetermined ion exchange capacity. The allylated agarose was treated with bromine and reacted with trimethylamine. Ion exchangers having three capacities were prepared (0.03 mmole/1, 0.11 mmole/1 and 0.17 mmole/1) . C. Determination of level of ligand. Inflection point titration under conditions of equilibrium directly on the ion exchanger in the pH range of 2-11 for weak ion exchangers. Strong ion exchangers were saturated with Cl " and the excess was washed off with distilled water, after which adsorbed chloride ion was eluated with a solution of AcO " and was determined by AgN0 3 titration of the eluate. 2. CHROMATOGRAPHY (PROTEINS) A. Chromatography for comparison of above-described agarose gel with tris ligand and with Q-ligand. Q-Sepharose® HP (Pharmacia Biotech, Uppsala, Sweden) with a capacity of 0.1710.3 mmole/ml, and the same coupling chemistry and matrix as in experiment 1 B. Gel according to above was packed in a HR 5/5 column (Pharmacia Biotech AB) to a gel height of 5-6 cm with a back pressure of about 5 bar. Sample: transferrin 1 mg/ml, ovalbumin 2 mg/ml, lactoglobulin 2 mg/ml, loop volume 50 μl Buffer A: piperazine 20 mM, pH 6.0 Buffer B: piperazine 20 mM, NaCl 1.0 M, pH 6.0 Flow: 0.2 ml/min Gradient volume: 40 ml UV-detector: 280 nm 0.05 AU Conductometer Maximum = 100 mS/cm Result: The tris-ion exchanger gave considerably higher dynam¬ ics as compared to the quaternary ion exchanger. See fiqure 1. B. pH dependence of the elution ionic strength for proteins on above-described agarose gels with tris-ligand and Q-ligand re¬ spectively. Column and gel according to 2 A. Flow 1 ml/min. Gradient: 20 ml to 0.5 M NaCl (40 ml to 1.0 M NaCl where appropriate) . Sam¬ ples are evident from figures 2A and 2B. Buffer by respective pH. pH 4 Hepes 20 mM-HCl pH .6 piperazine 20 mM-HCl pH 5 piperazine 20 mM-HCl pH 5.5 piperazine 20 mM-HCl pH 6 piperazine 20 mM-HCl pH 7 Bes 20 mM pH 7.5 Hepes 20 mM-NaOH pH 8.0 Hepes 20 mM-NaOH pH 8.2 tris 20 mM-HCl pH 9 taurine 20 mM-NaOH Result: See figures 2A and 2B in which conductivity at top maximum is plotted versus pH. Figure 2A shows the elution ionic strength for the different proteins on the quaternary ion ex- changer and figure 2B on the tris-ion exchanger. It is apparent that the elution ionic strength for the tris-ion exchanger in the pH range of 6±1 is considerably higher than for the quater- nary ion exchanger. Moreover, the difference between elution ionic strength for the protein binding most tightly to the gel and the one binding most weakly is considerably higher on the tris-ion exchanger than on the quaternary ion exchanger (up to pH about 7.5) . This shows that it is possible to increase the dynamics in the separation (greater range of ionic strength) by utilizing weak ion exchangers according to the invention. C. Comparison between different anion exchanging ligands coupled to cross-linked agarose gel according to above. Column according to 2 A. Gel according to 1 A. Samples: Transferrin (1 mg/ml), ovalbumin (1 mg/ml), β-lactoglobulin (1 mg/ml) . Buffer A: Piperazine 20 mM pH 6.0 Buffer B: Piperazine 20 mM, NaCl 1.0 M or 0.5 M, pH 6.0 Gradient volume: 40 ml (to 1 M) and 20 ml (to 0.5 M) re¬ spectively Other parameters as above. Result: Figure 3 shows the elution ionic strength in mS/cm at pH 6.0 for prepared ion exchangers for the studied model pro¬ teins. It is apparent that ion exchangers exhibiting a primary or secondary amino group at a distance of two carbon atoms away from a hydrogen binding group is distinguished from quaternary ligand for ability to separate the studied model proteins from each other by means of anion exchange chromatography. 3. CHROMATOGRAPHY (NUCLEIC ACID) MATERIAL Ligands: Experiments have been conducted with the same ligands as for proteins. Only results for tris-ion exchangers are pre¬ sented. Columns: HR 5/5 column packed to a bed volume of about 1 ml. Buffers : A. 20 mM sodium phosphate, pH 7.0. B. 2 M NaCl in buffer A, pH 7.0. C. 2 M NaCl & 4 M urea in buffer A, pH 7.0. D. 4 M urea in buffer A, pH 7.0 E. 20 mM Gly/NaOH, pH 9.0. F. 2 M NaCl in buffer E, pH 9.0. Sample: Synthetic phosphorothioate 25-mer oligonucleotiαe (mol weight 7 500 dalton) with a removed protecting group (trityl) . Concentration was 1.08 mmole/ml (8.1 mg/ml) and conductivity about 2 mS/cm. After synthesis and deprotection of trityl group the sample was rotation evaporated (to remove ammonia) and re¬ dissolved in deionized water. pH in the solution was typically adjusted to 8.2 before the sample was applied on the packed column (HR 5/5, bed volume 1 ml) . TEST PROTOCOL WITH RESULTS The sample (2 ml containing 16 mg synthetic oligonucleotide, total A 260 = 440) was applied to the column (HR 5/5, V t =l ml) , which was pre-equilibrated with buffer A or buffer E, which was followed by washing of unbound components with buffer A or E. Elution was conducted with buffer B and buffer C (for runs at pH 7.0) or with buffer F (for runs at pH 9.0) (elution rate 153 cm/h, temperature 21°C) . The eluate was collected as fractions A, B, C etc. Absorbance at 260 nm was measured for each frac- tion. The percentage distribution in relation to the total ab¬ sorbance applied to the column was calculated for each frac¬ tion. Collected fractions were desalted on Sephadex® G-25 equilibrated with deionized water. A suitable volume of each fraction was then analysed by capillary electrophoresis to de- ter ine purity. Experiment 1. Elution pH 7: Elution course see figure 4. The sample was applied on a col¬ umn equilibrated with buffer A. After elution of unbound mate- rial (fraction A,) with equilibration buffer, bound material was eluted with buffer B (fraction B) followed by buffer C (fraction C) . Based on absorbance measurements at A 260 the dis¬ tribution of oligonucleotide was: fraction A 6%, fraction B 32% and fraction C 62%. Analysis by capillary zone electrophoresis of fractions B and C showed that fraction B almost exclusively contained low molecular contaminants while fraction C contained 25-mer with a purity of at least 90%. The fact that this frac¬ tion was eluted with buffer containing 2 M NaCl and 4 M urea indicates that ionic and hydrogen bonds are involved in binding of oligonucleotide to the weak anion exchanger at pH 7. The experiment was repeated with the double amount of sample (32 mg 25-mer) . The results were generally the same as previ- ously and show that the anion exchanger has high adsorption ca¬ pacity for this type of oligonucleotides. The counterpart to fraction C showed even higher purity, which can indicate sam¬ ple-sample displacement with improved purity for the most tightly bound component (in this case 25-mer) . Experiment 2. Effect of urea, elution pH 7 The elution pattern is apparent from figure 5. In this ex¬ periment, experiment 1 was repeated except that, after washing with equilibrium buffer, the column was first eluted with buffer D (4 M urea) and then with buffer C. Figure 4 shows that small amounts of unbound material was washed with equilibrium buffer (fraction A) , that no bound components were eluted only with buffer D but that quantitative elution was obtained with buffer C (fraction B) . The results support that the binding to the weak anion exchanger is effected via interaction of ionic and hydrogen binding. Percentage distribution between the frac¬ tions was - fraction A 6% and fraction B 93%. Analysis by cap¬ illary electrophoresis showed that fraction B was 78% pure 25- mer with several small low molecular peaks. It is evident that an intermediate washing of the column with 2 M NaCl (buffer B, see experiment 1) results in elution of the majority of low mo¬ lecular compounds and a high purity of 25-mer in fraction C. Experiment 3. Gradient elution at pH 7. The elution pattern is apparent from figure 6. In this ex¬ periment, experiment 1 was repeated except that, after washing with equilibrium buffer, the column was eluted with a linear gradient from buffer A to buffer C (where in the concentration of NaCl & urea was increased simultaneously and linearly) or from buffer D to buffer C. In the latter case the column was first washed with buffer D to equilibrate it with the buffer containing 4 M urea. In both experiments elution of bound mate¬ rial occurred as a broad peak with several shoulders, espe¬ cially in the front-part. This peak was collected as two frac¬ tions (fraction B and fraction C, fraction A was material fol- 5 lowing after washing with equilibrium buffer) . Analysis by cap¬ illary zone electrophoresis showed that the front-part (fraction B) contained the majority of the low molecular con¬ taminants with a purity for 25-mer of about 40%. The later part of the elution curve (fraction C) contained almost exclusively 10 25-mer oligonucleotide with a purity of approximately 94%. Experiment 4. Elution at pH 9. Experiment 1 was repeated, with the exception that adsorption and elution of the mixture of oligonucleotides was performed at 15 pH 9 using buffer E and F. pH of the sample was adjusted to pH 8.2 and 2 ml (16.2 mg oligonucleotide) was applied to the col¬ umn, which had been equilibrated with buffer E. After elution of the unbound fraction (A) with buffer E, bound components (fraction B) were eluted with buffer F. Based on A 260 for frac- 20 tions A and B percent distribution was calculated to A l in fraction A and to 49% in fraction B. The elution pattern is shown in figure 7. The obtained result shows: 1. Opposed to the results for elution at pH 7, the bound components were eluted completely with 2 M NaCl (buffer 25 F) . At this pH the oligonucleotides seemed to be bound exclusively by ionic interaction without any hydrogen bonds. 2. Analysis by capillary electrophoresis showed that the un¬ bound components (fraction A) contained contaminants and 30 that fraction B had a purity of at least 60%. The purity of fraction B was increased to about 90% if it was eluted with a linear gradient from buffer E to buffer F. Experiments 5 and 6. (Significance of the pH of the sample) It was noted that separation of oligonucleotides at pH 9 was not reproducible. This was principally due to pH differences in the sample applied to the column, which can be seen from the elution pattern in figures 8A and 8B. The experiments are iden¬ tical with experiment 4 above. Figure 8A shows the elution pattern obtained when pH of the applied sample was 6.8. Approximately 75% of the bound compo- nents were eluted by buffer F but a lesser part (fraction C, 10% of applied A 260 ) is apparently so tightly bound that it re¬ quires buffer F for elution. The result is similar to the one obtained in experiment 1 and indicates that applied oligonu¬ cleotides are bound to the anion exchanger by ionic and hydro- gen bond forces. This can be due to the high density of charged groups on the oligonucleotides, which in turn gives them a high buffer capacity. The result could be that the pH of the anion exchanger actually is lower than equilibrium-pH, when the solu¬ tion of nucleotides (adjusted to pH 6.8) passes through the same. This hypothesis is probable since tris (hydroxymethyl) aminomethane is weakly dissociated at pH 9. Our results support this hypothesis, since pH in the unbound fraction (fraction A) was 8.9 while pH for the bound fraction (B) was 8.2, though pH in the elution buffer was 9.0 throughout the experiment. Figure 8B shows the elution pattern obtained when pH of the loaded sample was 9.0. In this case most of the loaded sample was unbound (88%) and about 10% was eluted with buffer F. This is clearly opposed to the results in figure 8A and shows that the oligonucleotides only are bound to the anion exchanger via ionic forces. The binding capacity of the anion exchanger is significantly lowered since tris (hydroxymethyl) aminomethane is only weakly ionized at this pH. The results obtained in experiment 5 show that separation of oligonucleotides on the tris-ion exchanger used is influenced by the pH of the sample as well as pH of the anion exchanger. The pH value can be varied between 7 and 9 for optimizing puri¬ fication of a crude product containing a mixture of syntheti¬ cally produced oligonucleotides. Experiment 7. Elution with a linear pH gradient. Experiment 1 was repeated, with the exception that, after elution of the unbound fraction A, oligonucleotides which bound to the matrix were eluted by a linear gradient (10 bed volumes) of buffer A (pH 7.0) to buffer F (pH 9.0) . The result showed that bound oligonucleotides started eluting from the matrix when pH of the effluent was about 8.5. The eluted peak was broad and the purity of the strongly bound component was compa¬ rable to the one obtained in experiment 3 above. The result shows that the synthetic oligonucleotide (25-mer) is bound to the matrix by a combination of ionic and hydrogen bonds up to pH 8.5 and by ionic interactions only at higher pH values. Experiment 8. Competing elution with Tris-HCl buffer. The object of this experiment was to investigate if a high concentration of Tris-HCl buffer (1 M, pH 7.0) could displace oligonucleotides bound to the matrix. The column was equili¬ brated by 50 mM Tris-HCl buffer (pH 7.0 (buffer I), and 2 ml of the sample was applied to the equilibrated column (compare ex¬ periment 1 above) . After elution of the unbound fraction (A) by equilibration buffer, the column was washed with the following buffers in the following order: Buffer II: 3 M NaCl in equilibration buffer (buffer I) Buffer III: 1 M Tris-HCl buffer, pH 7.0, and Buffer IV: 2 M NaCl, 1 M Tris-HCl, pH 7.0. The result showed that, of the loaded material: 1. 12.5 % did not bind to the column 2. 43 % was eluted by buffer II 3. 34 % was eluted by buffer III 4. 11 % was eluted by buffer IV. Thus it is clear that the majority of the tightly bound oli- gonucleotides (about 34 %) is eluted with 1 M Tris-HCl buffer, pH 7.0. The most likely explanation for this is that the combi¬ nation of tris (hydroxymethyl)methylamine and the counter ion Cl " does weaken hydrogen bonds and ionic bonds, respectively, between the ligand and bound oligonucleotides. This explanation is in line with the proposed mechanism for adsorption of oli¬ gonucleotides to tris-ligand and its analogs. The result also shows that higher ionic strength (see buffer IV) is required for eluting the most tightly bound fraction. This gives further support to our hypothesis, that binding at pH 7.0 of synthetic oligonucleotides to matrix, exhibiting tris-ligand, is due to ionic interaction with considerable enhancement through hydro¬ gen binding. Experiment 9. Separation of "trityl-on" from "trityl-off" syn- thetic oligonucleotides. This experiment was performed at pH 9.0 and followed the pro¬ cedure given in experiment 4 above. The crude sample contained a mixture of "trityl-on" and "trityl-off" synthetic oligonu¬ cleotides. Approximately 16 mg of the sample in 1 ml deionized water was applied to the column and the experiment was run ac¬ cording to experiment 4. Elution with buffer E (2 M NaCl in 20 mM Gly/NaOH buffer, pH 9.0) gave two well separated fractions (designated B and C) . Percentage distribution of material ab¬ sorbing at 260 nm (A 260 ) in the pooled fractions was : fraction A = 14 %, fraction B = 45 %, and fraction C = 44 %. Analysis by capillary zone electrophoresis showed that fraction A exclu- sively contained low molecular contaminants, fraction B con¬ tained mainly the "trityl-off" variant of the synthetic oli¬ gonucleotide with a purity of 80 %, and the most retarded frac¬ tion C had a purity of at least 80 % and contained the "trityl- on" variant of the 25-mer oligonucleotide. This result, together with the earlier described, illustrate the great potential of the invention as a chromatography method for readily purification of synthetic oligonucleotides in high yield and with high purity. By choosing optimal pH conditions during the adsorption process the capacity for oligonucleotide of the matrix used can be higher than 20 mg/ml adsorbent.

Claims: CLAIMS 1. Process for separating off a peptide or a nucleic acid, com¬ prising contacting an aqueous solution containing the peptide or the nucleic acid with an anion exchanger (I) under such con¬ ditions that the anion exchanger (I) binds substances in the solution so that the desired peptide or nucleic acid is de¬ tached from at least one substance in the solution, character¬ ized in that a. the anion exchanger (I) exhibits ligands, which i. contain a primary, secondary or tertiary amino group and ii. are covalently bound, possibly through an organic bridge, to an organic polymer (matrix) , b. on a carbon atom at a distance of 2 or 3 atoms away from an amino nitrogen there is a hydroxyl group or a primary, secondary or tertiary amino group, and c. the maximum elution ionic strength in the pH range 2-14 for at least one of the proteins transferrin, ovalbumin 1, ovalbumin 2, β-lactoglobulin 1 and β-lactoglobulin 2 on the anion exchanger (I) is higher, preferably at least 125% higher, than the elution ionic strength required on a quaternary anion exchanger (II) with Q-group ( (CH 3 ) 3 N + -; the same matrix, the same coupling group from the quater¬ nary nitrogen and in towards the matrix, the same level of ligand as for the anion exchanger (I) and the elution ionic strength measured at the same pH for anion exchang¬ ers I and II, with the proviso that chromatofocusing and separation on ECTEOLA-cellulose are not included. 2. Process according to claim 1, characterized in that the an ¬ ion exchanger has the structure ligand ligand arm (B) plus matrix (M) FORMULA 1 wherein a. means that the ligand arm B is replacing a group R 1 _ 6 or a hydrogen in any of the groups R^g in the ligand, b. M is a polymer matrix containing further anion exchanging ligands, c. B is an organic structure which lacks hydrolytically un¬ stable structures, such as silane, carboxylic acid ester (-COO-) or carboxylic acid amide (-CONH-) , and which con- tains hydrocarbon chains selected among the same carbon chains as R^g, d. n is an integer of 1 or 2, typically 1, e. R^ are selected among hydrogen or linear, branched or cyclic saturated or unsaturated hydrocarbon group, which can be monovalent or bivalent, with a carbon chain which optionally is disrupted by one or more amino nitrogen- or ether oxygen atoms (-NR 7 - and -0- respectively) and/or has one or more hydrogens replaced by an amino group (- N + R 8 R 9 Rι 0 ) °r b y a group -OR n , with the proviso that: A. if Rι- 6 is a bivalent group then this comprises two groups Rι_ 6 , which together with at least one of the atoms written in bold letters in formula I form a 5 or 6 membered ring, and B. both R 5 and R 6 can not be selected among methyl and ethyl, f. R 7 _ n are selected among the same groups as R x _ 6 , prefera¬ bly lower unsubstituted alkyl (C^g) and hydrogen, g. X is -OH or -NR 12 R 13 , R 12 _ 13 being selected among the same groups as Rx- , h. anion exchangers which have been prepared by coupling triethanol amino to cellulose via epoxide are not in¬ cluded. 3. Process according to claim 2, characterized in that B is re¬ placing Rx or R 2 . 4. Process according to any of the claims 2-3, characterized in that B is a linear, branched or cyclic saturated hydrocarbon chain optionally disrupted by ether oxygen atoms and which optionally has one or more hydrogens replaced by hydroxyl. 5. Process according to any of the claims 2-4, characterized in that B is -CH 2 CH0HCH 2 -O-CH 2 -, -CH 2 CHOHCH 2 -0- (CH 2 ) 4 -0-CH ,-, —CH 2 ~. 6. Process according to any of the claims 2-5, characterized in that n is 1 and R x _ 4 are hydrogen. 7. Process according to any of the claims 2-6, characterized in that R 5 and/or R 6 is hydrogen. 8. Process according to any of the claims 2-7, characterized in that X is a hydroxyl group. 9. Process according to any of the claims 2-8, characterized in that at least one of R 5 _ 6 contains a group -N + R 8 R 9 R 10 ) or -0R U at a distance of two carbon atoms away from the nitrogen atom to which R 5 . 6 bind, wherein R 8 -n are selected among the same groups as R lf R 2 , R 5 and R 6 , preferably hydrogen or lower alkyl (1-6 carbon atoms) . 10. Process according to any of the claims 2-9, characterized in that the ligand is selected among: -CHOHCH 2 NH 2 ; -CHOHCH 2 NH(CH 2 ) 3 NH(CH 2 ) 3 NH 2 ; -CH0HCH 2 N[CH 2 ) 3 NH 2 ] 2 ; -CHOHCH 2 NH[C (CH 3 ) 3 ] ; -CHOHCH 2 NHCH 2 CH 2 OH; -CHOHCH 2 N(CH 2 CH 2 OH) 2 ; -CHOHCH 2 NHC(CH 2 0H) 3 ; -CHOHCH 2 NHCH(CH 2 OH) 2 ; -CHOHCH 2 NHCH : CH 2 CH 3 ; -CHOHCH 2 NHCH 2 CHOHCH 2 OH; -CHOHCH 2 NHC(CH 3 ) (CH 2 OH) 2 ; -CHOHCH 2 NHCH 2 (CHOH) 4 CH 2 OH; -CHOHCH 2 N [C (CH 2 OH) 3 ] (CH 2 ) 3 NHC (CH 2 OH) 3 . 11. Process according to any of the claims 2-10, characterized in that a peptide is separated off and that the anion ex- changer exhibits ligands selected among: -CHOHCH 2 NH 2 ; -CHOHCH 2 NH (CH 2 ) 3 NH (CH 2 ) 3 NH 2 ; -CHOHCH 2 NHCH CH 2 OH; -CHOHCH 2 NHCH(CH 2 OH) 2 ; -CHOHCH 2 NHCH 2 CHOHCH 2 OH; -CHOHCH 2 NHC (CH 3 ) (CH 2 OH) 2 ; -CHOHCH 2 NHC (CH 2 OH) 3 ; -CHOHCH 2 N [C (CH 2 OH) 3 ] (CH 2 ) 3 NHC (CH 2 OH) 3 . 12. Process according to any of the claims 1-11, characterized in that a peptide is separated off by adsorption to the an¬ ion exchanger and that adsorbed peptide is eluted by a. an agent which breaks hydrogen bonds, e.g. urea or guanidine and/or b. salt, and/or c. change of pH. 13. Process according to any of the claims 1-12, character¬ ized in that a peptide is separated off and that the peeptide is applied to the anion exchanger in a solution having an ionic strength of > 15 mS/cm. 14. Process according to any of the claims 2-10, characterized in that nucleic acid is separated off and that the anion ex¬ changer exhibits ligands selected among: -CHOHCH 2 NH [C (CH 3 ) 3 ] ; -CHOHCH 2 NHCH (CH 2 OH) 2 ; -CHOHCH 2 NHC (CH 2 OH) 3 ; -CHOHCH 2 NHCH 2 CH 2 OH; -CH 2 CHOHCH 2 NHCH 2 CH 2 CH 3 . 15. Process according to any of the claims 2-10 and 14, charac- terized in that nucleic acid is separated off by adsorption to the ion exchanger and that adsorbed nucleic acid subse¬ quently is eluted by a. an agent which breaks hydrogen bonds, e.g. urea or guanidine and/or, b. salt and/or c. increasing of pH so that the ligands are completely or partially unloaded. 16. Process according to any of the claims 2-10 and 14-15, characterized in that the nucleic acid is a synthetic oli¬ gonucleotide. 17. Process according to any of the claims 1-16, characterized in that the anion exchanger is according to any of the claims 18-24. 18. Anion exchanger characterized in that it has the structure ligand ligand arm (B) plus matrix (M) FORMULA 1 where a. means that the ligand arm B is replacing a group R x _ 6 or a hydrogen in any of the groups R x _ 6 in the ligand, b. M is a polymer matrix containing further anion exchanging ligands, c. B is an organic structure which lacks hydrolytically un¬ stable structures, such as silane, carboxylic acid ester (-COO-) or carboxylic acid amide (-CONH-) , and which con¬ tains hydrocarbon chains selected among the same carbon chains as R^, d. n is an integer of 1 or 2, typically 1, e. i. R lf R 2 , R 3 and R 4 are selected among hydrogen and linear, branched or cyclic saturated or unsaturated hydrocarbon group, which can be monovalent or biva¬ lent, with a carbon chain which optionally is dis¬ rupted by one or more amino nitrogen- or ether oxygen atoms (-NR 7 - and -0- respectively) and/or has one or more hydrogens replaced by an amino group (-N + R 8 R 9 R 10 ) or by a group -0R n , with the proviso that A. if any of the groups is bivalent then this com¬ prises two groups Rx- , which together with at least one of the atoms written in bold letters in formula I form a 5 or 6 membered ring, ii. R 5 and R 6 are selected among the same groups as R x _ 4 with the provisos that 5 B. if one or two of the groups R 5 and R 6 contain one or more nitrogen atoms then at least one of the groups also contains one or more oxygen atoms (- 0R n , where R n is according to paragraph f be¬ low) , 10 C. both R 5 and R 6 cannot at the same time be se¬ lected among methyl and ethyl, f. R _u are selected among the same groups as R^, prefera¬ bly lower unsubstituted alkyl (C^g) and hydrogen, g. X is -OH or -NR 12 R 13 , wherein R 12 and R 13 are selected 15 among the same groups as R^ , h. anion exchangers prepared by coupling of triethanol amine to cellulose via a reaction with epoxide are not in¬ cluded. 20 19. Anion exchanger according to claim 18, characterized in that B replaces Ri or R 2 . 20. Anion exchanger according to any of the claims 18-19, char¬ acterized in that B is a linear, branched or cyclic satu- 25 rated hydrocarbon chain which optionally is disrupted by ether oxygen atoms and which optionally has one or more hy¬ drogens replaced by hydroxyl. 21. Anion exchanger according to any of the claims 18-20, char- 30 acterized in that B is -CH 2 CHOHCH 2 -0-CH 2 -; -CH 2 CH0HCH 2 -0-(CH 2 ) 4 -0-CH 2 -; or -CH 2 -. 22. Anion exchanger according to any of the claims 18-21, char¬ acterized in that n is 1 and that R x _ 4 are hydrogen. 23. Anion exchanger according to any of the claims 18-22, char- actβrized in that R 5 and/or R 6 is hydrogen. 24. Anion exchanger according to any of the claims 18-23, char¬ acterized in that the ligand is selected among: -CHOHCH 2 NH 2 ; -CHOHCH 2 N [CH 2 ) 3 NH 2 ] 2 ; -CHOHCH 2 NH [C (CH 3 ) 3 ] ; -CHOHCH 2 NHCH 2 CH 2 OH; -CHOHCH 2 N (CH 2 CH 2 OH) 2 ; -CHOHCH 2 NHC (CH 2 OH) 3 ; -CHOHCH 2 NHCH (CH 2 OH) 2 ; -CHOHCH 2 NHCH 2 CHOHCH 2 OH; -CHOHCH 2 NHC(CH 3 ) (CH 2 OH) 2 ; -CHOHCH 2 NHCH 2 (CHOH) 4 CH 2 OH; -CHOHCH 2 N[C(CH 2 OH) 3 ] (CH 2 ) 3 NHC (CH 2 OH) 3 ; -CHOHCH 2 NHCH 2 CH 2 CH 3 .

Inventors: BELEW MAKONNEN, BERGLUND ROLF, BERGSTROEM JAN, SOEDERBERG LENNART, BELEW, MAKONNEN, BERGLUND, ROLF, BERGSTROEM, JAN, SOEDERBERG, LENNART
Applicants: BELEW MAKONNEN, BERGLUND ROLF, BERGSTROEM JAN, PHARMACIA BIOTECH AB, SOEDERBERG LENNART, BELEW, MAKONNEN, BERGLUND, ROLF, BERGSTROEM, JAN, SOEDERBERG, LENNART
Application year: 1997
Main classification: B01D15
IPC codes: B01D15, B01J41, C07K1